Mebeverine

Generic name
Mebeverine
Brand name
ATC Code
A03AA04

Mebeverine

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Irritable bowel syndrome
  • Oral
    • Normal preparation (immediate release)
      • ≥ 10 years
        • 405 mg/day in 3 doses.
      • ≥ 10 years
        [2]
        • 405 mg/day in 3 doses.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Synthetic anticholinergics, quaternary ammonium compounds
A03AB02
Other drugs for functional gastrointestinal disorders
A03AX15
A03AX13

References

  1. Abbott B.V., SmPC Duspatal tablet modified release (RVG 11657) 08-06-2015, www.geneesmiddeleninformatiebank.nl
  2. Abbott B.V., SmPC Duspatal coated tablet (RVG 07904) 08-06-2015, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose